Universal Detection Technology (UDTT.OB)
Interview with:
Jacques Tizabi, Chairman and CEO
&
Amir Ettehadieh, Director of Research and Development
Business News, Financial News, Stocks, Money & Investment Ideas, CEO Interview
and Information on their
device for continuous unattended monitoring of airborne bacterial spores in large public spaces, with real-time automated alert functionality, which functions as an Anthrax ‘Smoke Detector’.

wpe4D.jpg (6486 bytes)

Cover Story

CEOCFO Interview Index

CEOCFO Current Issue

Future Features

Analyst Interviews

Corporate Financials

Archived Interviews
 

About CEOCFOinterviews.com

Contact & Ordering

 

Universal Detection Technology, in collaboration with NASA’s JPL, is in the process of developing an Anthrax ‘Smoke Detector’, which is a real time biological weapon detection device

wpe65.jpg (3123 bytes)

Technology
Security
(UDTT.OB-OTC)

Universal Detection Technology


wpe6A.jpg (5511 bytes)

Jacques Tizabi
Chairman and
Chief Executive Officer


wpe6C.jpg (4974 bytes)

Amir Ettehadieh
Director of
Research and Development

Interview conducted by:
Walter Banks
Co-Publisher

CEOCFOinterviews.com
November 2003

Universal Detection Technology (OTC:BB - UDTT) has specialized in manufacturing airborne particulate and pollutant detection devices for the past 30 years. With the emergence of the threat of bio-terrorism and the evident lack of preparedness of the country to such attacks, the Company focused its research and development efforts in developing a real time biological weapon detection device. The attacks of September 11, 2001 and the subsequent spread of anthrax spores have created a new sense of urgency in public health systems across the world, and especially in the United States. On June 13, 2002 President Bush signed into law legislation allocating $4.3 billion to protect the country against future bio-terrorism. “What we actually developed over the years was a device capable of sampling the air at a rate faster than a human breathes, and of capturing particles, which are the specific and very minute size, which then coincide with the types of things that we are talking about.” Offers Jacques Tizabi, Chairman & CEO of Universal Detection Technology, “Therefore, what Universal Detection has created is the mechanism of that collection for very specific size of particles, because only then would you be able to have those samples ready for detection. In addition, our device has always been autonomous, because of this collection mechanism.” Amir Ettehadieh, director of Research and Development for Universal Detection Technology tells us, “The advantage that the Universal Detection device has is basically three fold. First, it is faster than any other device out there. It will give you positive results within 15 minutes of exposure to the Anthrax bacteria. The second advantage that it has is that it works on its own; you do not need an attendant or a technician to be there constantly. If there is a positive detection result, it will give off an alarm and notify the appropriate individual. The third major advantage is that our device never gives false positive results, which is a serious drawback to the other technologies that are out there. For example, the PCR DNA based technology can give a positive result from pollen or other organic material. In contrast, our device only gives a positive result in the presence of the Bacterial spores.” Addressing the investment community Mr. Tizabi says, “It is very competitive and difficult if you want to develop fully proprietary technology within a small company and then take it to a government sector. However, when you are in partnership with NASA’s Jet Propulsion Laboratory, as we are, and you bring that kind of credibility and science and government backing in partnership with yourself, that is where you all of a sudden find yourself having a lot of potential for the future.”

In August 2002, UDT entered its first collaborative partnering agreement in a deal with NASA’s Jet Propulsion Laboratory (JPL). Under the terms of the agreement, JPL will develop its proprietary bacterial spore detection technology for integration into UDT's developing bio-terrorism detection device. With JPL's technology fully integrated, the targeted operating scenario for the UDT device is continuous unattended monitoring of airborne bacterial spores in large public spaces, with real-time automated alert functionality.

UDT’s device, developed in collaboration with JPL, essentially functions as an Anthrax ‘Smoke Detector.’ The device continuously monitors the air for Anthrax spores. It then uses a microwave to “pop” the spores thus releasing a chemical from inside the spores called dipicolinic acid, which is unique to bacterial spores. This dipicolinic acid instantaneously reacts with the chemical sensor in the solution. The sensor triggers an intense green luminescence when viewed under ultraviolet light. The intensity of the luminescence corresponds to the concentration of bacterial spores in the sample. If an increase in spore concentration is detected, an alarm sounds notifying both a buildings internal security as well as local emergency services through the devices landline or wireless networking capability. The devices response time is 15 minutes, fast enough to help prevent widespread contamination.





Instant Access:
To find out more about:
Universal Detection Technology (UDTT.OB) you may order the complete text of our interview. To view a copy of this highly informative interview, left click here: ViewUDTT.OB

disclaimer

Newsflash!

To view Releases highlight & left click on the company name!

 

ceocfointerviews.com does not purchase or make
recommendation on stocks based on the interviews published.

.